Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 6,300 | 6,555 | 7,913 | 6,451 | 4,637 |
| Cost of Goods | 2,609 | 3,100 | 3,591 | 3,197 | 4,138 |
| Gross Profit | 3,691 | 3,455 | 4,322 | 3,254 | 499 |
| Operating Expenses | 14,572 | 14,820 | 13,773 | 13,722 | 12,928 |
| Operating Income | -10,272 | -11,265 | -8,860 | -10,271 | -12,291 |
| Interest Expense | 14 | 2 | 1 | 2 | 3 |
| Other Income | 12 | 76 | 84 | -346 | 1,500 |
| Pre-tax Income | -10,274 | -11,191 | -8,777 | -10,619 | -10,794 |
| Income Tax | -616 | 19 | 6 | 13 | 23 |
| Net Income Continuous | -9,658 | -11,210 | -8,783 | -10,632 | -10,817 |
| Net Income | $-9,658 | $-11,210 | $-8,783 | $-10,632 | $-10,817 |
| EPS Basic Total Ops | -0.23 | -0.27 | -0.21 | -0.27 | -0.30 |
| EPS Basic Continuous Ops | -0.23 | -0.27 | -0.21 | -0.27 | -0.30 |
| EPS Diluted Total Ops | -0.23 | -0.27 | -0.21 | -0.27 | -0.30 |
| EPS Diluted Continuous Ops | -0.23 | -0.27 | -0.21 | -0.27 | -0.30 |
| EBITDA(a) | $-9,386 | $-10,476 | $-8,088 | $-9,472 | $-11,345 |